Profile of Coagulation Marker and The Influence Factors in Central Nervous System Tumor

Yunni Diansari, Mediarty Syahrir, Sri Novianty Yusuf

Abstract


Brain tumors have the highest percentage of thrombosis compared to other types of malignancies. Hypercoagulation is a risk for thromboembolic events in patients with malignancy. Hypercoagulation conditions are frequentlyfound in patients with malignancy arising from the aptitudeof tumor cells to activate the coagulation system. This condition can be detected through coagulation markers in the blood. This marker isPT, APTT, INR, Fibrinogen and D-Dimer.This research is a descriptive analytic study using secondary data from medical records of patients with central nervous system (CNS) tumors. The inclusion criteria were CNS tumor patients> 18 years old and had been diagnosed with CNS tumor. Coagulation markers are recorded based on the results of the initial laboratory examination upon entering the hospital, consisting of D-Dimer, PT, APTT, Fibrinogen, INR.There were 124 researchsubjects, consisting of 60 men and 64 women. Most research subjects are in the age range of 40-49 years (54.8%). Hypercoagulation conditions were found in 92.74% of study subjects. The most common accompanying conditionwas hypertension (22.6%). There were no significant differences in the hypercoagulable conditions in groups with and without accompanying conditions.Hypercoagulation was found in most research subjects. There are no factors that influence the hypercoagulation condition in this study.


Keywords


hypercoagulation, accompanying conditions, coagulation markers, CNS tumors

Full Text:

PDF


DOI: https://doi.org/10.36706/mks.v51i4.10071

Refbacks

  • There are currently no refbacks.




 

Indexed in:

        .                 

 


Editorial Office

Fakultas Kedokteran Universitas Sriwijaya
Jl. Dr. Moehammad Ali Kompleks RSMH Palembang 30126, Indonesia

Telp. 0711-316671, Fax.: 0711-316671

Email:mksfkunsri@gmail.com 

 
Flag Counter
Web Analytics View My Stats